AbCellera IPO Presentation Deck

INTELLECTUAL PROPERTY GLOBAL INTELLECTUAL WITH FOUNDATIONAL • 40+ applications worldwide • 15 patent families 35* PATENTS PROPERTY PORTFOLIO PATENTS. Methods for Assaying Expect to expire 2034 Owned or exclusively licensed Immune Rep Seq Expect to expire 2034 EXEMPLARY PATENT GROUPS Foundational claims on high-throughput single-cell secretion assays with application to antibody discovery & clone selection COVID-19 Expect to expire no earlier than 2040 AbCellera

View entire presentation